Projects
Joint Action on Cardiovascular Diseases and Diabetes (JACARDI). University of Antwerp
JACARDI Joint Action on CARdiovascular Diseases and DIabetes KU Leuven
The JACARDI project aligns with the objectives of the European Union Health Programme (EU4H) by focusing on the reduction of NCDs at both individual and societal levels. It seeks to reduce the burden of CVD and DM while increasing awareness of related risks and the acceptance of innovative lifestyle interventions.
The project’s relevance extends to addressing the diverse needs of the people in Europe, harmonizing health systems, and ...
RADical reduction of OXidative stress in cardiovascular diseases. KU Leuven
Cardiovascular disease (CVD) constitutes a major and increasing health burden in developed countries. The prediction is that the prevalence of these conditions will increase by ~60% over the next 20 years. Therefore, the development of novel treatments for patients with CVD becomes more and more urgent. Oxidative stress is an important molecular contributor to the pathogenesis of CVD. However, oxidative stress-related therapeutic strategies ...
Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients Ghent University
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Besides established risk factors such as elevated blood pressure, blood glucose or lipid levels, circulating proteomic as well as genetic markers allow further stratification of patients. While some of these markers can be measured routinely in low-threshold healthcare institutions, others require access to highly specialized and costly laboratory environment which ...
CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease Vrije Universiteit Brussel
WHO estimates 17.7 million people die each year from cardiovascular disease (CVD), an estimated 31% of all deaths worldwide. While progress with conventional treatments is making incremental gains, there remains a need to develop innovative therapeutic approaches. Gene therapy has gained significant momentum, mainly for treatment of rare monogenetic diseases. Marketing authorization for gene therapy products has not impacted ...
Use of Microorganisms for Carotenoids Delivery: Next Generation of Probiotics for Cardiovascular Disease Ghent University
CARODEL aims to valorise the result from the previous FP7 COLORSPORE, project, in which initial isolation and characterization work was performed on Bacillus strains producing gastric-stable carotenolds. As the stability in the gastrointestinal Iract (GIT), antioxidant activity and biosavailability of particular Bacillus carotenoids was shown to be higher than those of common dietary carotenoids, the conclusions from COLORSPORE provided ...
SmartCHANGE : AI-based long-term health risk evaluation for driving behaviour change strategies in children and youth Vrije Universiteit Brussel
obesity and low physical fitness resulting from an unhealthy lifestyle. Targeting children and youth for lifestyle interventions has been
suggested because (1) early precursors of most NCDs are already present at this age, (2) childhood and adolescence are critical periods
for the acquisition of ...
EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspects Ghent University
The 3-year EURAMED rocc-n-roll project aims to propose an integrated and coordinated European approach to research and innovation in medical applications of ionising radiation and related radiation protection based on stakeholder consensus and existing activities in the field (incl. existing SRAs of radiation protection platforms, EC health and digitisation programmes, EURATOM-funded projects, SAMIRA initiative). To achieve this, research ...
Innovation in modelling Placenta for Maternal and Fetal Health KU Leuven
The placenta is the least understood human organ but arguably one of the most important”-NIH Human Placenta Project . Innovation in Modelling Placenta for Maternal and Fetal Health (iPLACENTA) is a European Training Network (ETN), and will act as a springboard for promoting international, intersectoral and multi/inter-disciplinary training, career development and collaboration of fifteen early-stage researchers (ESRs) in Maternal and Fetal ...